Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group

Kevin R. King; Luanda P. Grazette; Dina N. Paltoo; John T. McDevitt; Samuel K. Sia; Paddy M. Barrett; Fred S. Apple; Paul A. Gurbel; Ralph Weissleder; Hilary Leeds; Erin J. Iturriaga; Anupama K. Rao; Bishow Adhikari; Patrice Desvigne-Nickens; Zorina S. Galis; Peter Libby

doi:10.1016/j.jacbts.2016.01.008

Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group

Kevin R. King, Luanda P. Grazette, Dina N. Paltoo, John T. McDevitt, Samuel K. Sia, Paddy M. Barrett, Fred S. Apple, Paul A. Gurbel, Ralph Weissleder, Hilary Leeds, Erin J. Iturriaga, Anupama K. Rao, Bishow Adhikari, Patrice Desvigne-Nickens, Zorina S. Galis, Peter Libby

School of Medicine

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Abstract

Point-of-care technologies (POC or POCT) are enabling innovative cardiovascular diagnostics that promise to improve patient care across diverse clinical settings. The National Heart, Lung, and Blood Institute convened a working group to discuss POCT in cardiovascular medicine. The multidisciplinary working group, which included clinicians, scientists, engineers, device manufacturers, regulatory officials, and program staff, reviewed the state of the POCT field; discussed opportunities for POCT to improve cardiovascular care, realize the promise of precision medicine, and advance the clinical research enterprise; and identified barriers facing translation and integration of POCT with existing clinical systems. A POCT development roadmap emerged to guide multidisciplinary teams of biomarker scientists, technologists, health care providers, and clinical trialists as they: 1) formulate needs assessments; 2) define device design specifications; 3) develop component technologies and integrated systems; 4) perform iterative pilot testing; and 5) conduct rigorous prospective clinical testing to ensure that POCT solutions have substantial effects on cardiovascular care.

Original language	English (US)
Pages (from-to)	73-86
Number of pages	14
Journal	JACC: Basic to Translational Science
Volume	1
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jacbts.2016.01.008
State	Published - Feb 1 2016

Keywords

biomarkers
clinical trials
precision medicine

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacbts.2016.01.008

Cite this

King, K. R., Grazette, L. P., Paltoo, D. N., McDevitt, J. T., Sia, S. K., Barrett, P. M., Apple, F. S., Gurbel, P. A., Weissleder, R., Leeds, H., Iturriaga, E. J., Rao, A. K., Adhikari, B., Desvigne-Nickens, P., Galis, Z. S., & Libby, P. (2016). Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group. JACC: Basic to Translational Science, 1(1-2), 73-86. https://doi.org/10.1016/j.jacbts.2016.01.008

King, KR, Grazette, LP, Paltoo, DN, McDevitt, JT, Sia, SK, Barrett, PM, Apple, FS, Gurbel, PA, Weissleder, R, Leeds, H, Iturriaga, EJ, Rao, AK, Adhikari, B, Desvigne-Nickens, P, Galis, ZS & Libby, P 2016, 'Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group', JACC: Basic to Translational Science, vol. 1, no. 1-2, pp. 73-86. https://doi.org/10.1016/j.jacbts.2016.01.008

@article{1dde912b32c045c9a12585b25f243de4,

title = "Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group",

abstract = "Point-of-care technologies (POC or POCT) are enabling innovative cardiovascular diagnostics that promise to improve patient care across diverse clinical settings. The National Heart, Lung, and Blood Institute convened a working group to discuss POCT in cardiovascular medicine. The multidisciplinary working group, which included clinicians, scientists, engineers, device manufacturers, regulatory officials, and program staff, reviewed the state of the POCT field; discussed opportunities for POCT to improve cardiovascular care, realize the promise of precision medicine, and advance the clinical research enterprise; and identified barriers facing translation and integration of POCT with existing clinical systems. A POCT development roadmap emerged to guide multidisciplinary teams of biomarker scientists, technologists, health care providers, and clinical trialists as they: 1) formulate needs assessments; 2) define device design specifications; 3) develop component technologies and integrated systems; 4) perform iterative pilot testing; and 5) conduct rigorous prospective clinical testing to ensure that POCT solutions have substantial effects on cardiovascular care.",

keywords = "biomarkers, clinical trials, precision medicine",

author = "King, {Kevin R.} and Grazette, {Luanda P.} and Paltoo, {Dina N.} and McDevitt, {John T.} and Sia, {Samuel K.} and Barrett, {Paddy M.} and Apple, {Fred S.} and Gurbel, {Paul A.} and Ralph Weissleder and Hilary Leeds and Iturriaga, {Erin J.} and Rao, {Anupama K.} and Bishow Adhikari and Patrice Desvigne-Nickens and Galis, {Zorina S.} and Peter Libby",

note = "Publisher Copyright: {\textcopyright} 2016 The Authors",

year = "2016",

month = feb,

day = "1",

doi = "10.1016/j.jacbts.2016.01.008",

language = "English (US)",

volume = "1",

pages = "73--86",

journal = "JACC: Basic to Translational Science",

issn = "2452-302X",

publisher = "Elsevier Inc.",

number = "1-2",

}

TY - JOUR

T1 - Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research

T2 - National Heart, Lung, and Blood Institute Working Group

AU - King, Kevin R.

AU - Grazette, Luanda P.

AU - Paltoo, Dina N.

AU - McDevitt, John T.

AU - Sia, Samuel K.

AU - Barrett, Paddy M.

AU - Apple, Fred S.

AU - Gurbel, Paul A.

AU - Weissleder, Ralph

AU - Leeds, Hilary

AU - Iturriaga, Erin J.

AU - Rao, Anupama K.

AU - Adhikari, Bishow

AU - Desvigne-Nickens, Patrice

AU - Galis, Zorina S.

AU - Libby, Peter

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Point-of-care technologies (POC or POCT) are enabling innovative cardiovascular diagnostics that promise to improve patient care across diverse clinical settings. The National Heart, Lung, and Blood Institute convened a working group to discuss POCT in cardiovascular medicine. The multidisciplinary working group, which included clinicians, scientists, engineers, device manufacturers, regulatory officials, and program staff, reviewed the state of the POCT field; discussed opportunities for POCT to improve cardiovascular care, realize the promise of precision medicine, and advance the clinical research enterprise; and identified barriers facing translation and integration of POCT with existing clinical systems. A POCT development roadmap emerged to guide multidisciplinary teams of biomarker scientists, technologists, health care providers, and clinical trialists as they: 1) formulate needs assessments; 2) define device design specifications; 3) develop component technologies and integrated systems; 4) perform iterative pilot testing; and 5) conduct rigorous prospective clinical testing to ensure that POCT solutions have substantial effects on cardiovascular care.

AB - Point-of-care technologies (POC or POCT) are enabling innovative cardiovascular diagnostics that promise to improve patient care across diverse clinical settings. The National Heart, Lung, and Blood Institute convened a working group to discuss POCT in cardiovascular medicine. The multidisciplinary working group, which included clinicians, scientists, engineers, device manufacturers, regulatory officials, and program staff, reviewed the state of the POCT field; discussed opportunities for POCT to improve cardiovascular care, realize the promise of precision medicine, and advance the clinical research enterprise; and identified barriers facing translation and integration of POCT with existing clinical systems. A POCT development roadmap emerged to guide multidisciplinary teams of biomarker scientists, technologists, health care providers, and clinical trialists as they: 1) formulate needs assessments; 2) define device design specifications; 3) develop component technologies and integrated systems; 4) perform iterative pilot testing; and 5) conduct rigorous prospective clinical testing to ensure that POCT solutions have substantial effects on cardiovascular care.

KW - biomarkers

KW - clinical trials

KW - precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85010424124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010424124&partnerID=8YFLogxK

U2 - 10.1016/j.jacbts.2016.01.008

DO - 10.1016/j.jacbts.2016.01.008

M3 - Review article

C2 - 26977455

AN - SCOPUS:85010424124

SN - 2452-302X

VL - 1

SP - 73

EP - 86

JO - JACC: Basic to Translational Science

JF - JACC: Basic to Translational Science

IS - 1-2

ER -

Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this